Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Donepezil Hydrochloride Orally Disintegrating Tablets

Approval Number

国药准字H20243527

Company扬子江药业集团上海海尼药业有限公司

Registration Date

April 17, 2024

Drug Information

Generic Name

盐酸多奈哌齐口崩片

Dosage Form

口崩片

Strength

5mg

Drug Type

化学药品

Registration Date

April 17, 2024

Company Information

Applicant Company

Company Name扬子江药业集团上海海尼药业有限公司

Company Address

浦东新区周浦镇沪南路3999号

Manufacturing Company

Company Name扬子江药业集团上海海尼药业有限公司

Company Address

上海市浦东新区周浦镇沪南路3999号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

盐酸多奈哌齐口崩片 - NMPA 批准文号 | MedPath